A Study to Evaluate the Effect of Repeat Doses of GW870086X in Mild to Moderate Asthmatics

Status:
Completed

Trial end date:
2009-12-01

Target enrollment:

Participant gender:

This study will measure the effect of repeat inhaled doses of GW870086X on lung function.

Phase 2

GlaxoSmithKline